10,334
Total Claims
$1.5M
Drug Cost
1,339
Beneficiaries
$1,153
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-24%
Cost per patient vs peers
$1,153 vs $1,524 avg
+19%
Brand preference vs peers
16.3% vs 13.7% avg
Brand vs Generic
84% generic
Brand: 1,680 claims · $1.3M
Generic: 8,654 claims · $206K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 746 | $692K |
| Rivaroxaban | 351 | $329K |
| Ticagrelor | 131 | $97K |
| Sacubitril/Valsartan | 74 | $82K |
| Dronedarone Hcl | 43 | $45K |
| Evolocumab | 34 | $23K |
| Dofetilide | 62 | $17K |
| Empagliflozin | 14 | $16K |
| Dapagliflozin Propanediol | 23 | $14K |
| Alirocumab | 22 | $14K |
| Metoprolol Succinate | 590 | $14K |
| Atorvastatin Calcium | 671 | $13K |
| Ranolazine | 54 | $11K |
| Diltiazem Hcl | 209 | $9,497 |
| Metoprolol Tartrate | 1,006 | $8,465 |
Prescribing Profile
59
Unique Drugs
$1.1M
Patient Profile
76
Avg Age
47%
Female
1.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data